These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15940632)

  • 1. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.
    Bourdu S; Dapoigny M; Chapuy E; Artigue F; Vasson MP; Dechelotte P; Bommelaer G; Eschalier A; Ardid D
    Gastroenterology; 2005 Jun; 128(7):1996-2008. PubMed ID: 15940632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome.
    Matricon J; Muller E; Accarie A; Meleine M; Etienne M; Voilley N; Busserolles J; Eschalier A; Lazdunski M; Bourdu S; Gelot A; Ardid D
    Neurogastroenterol Motil; 2013 Nov; 25(11):e740-54. PubMed ID: 23902154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2020 Nov; 887():173576. PubMed ID: 32949597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphrinB2/ephB2 activation facilitates colonic synaptic potentiation and plasticity contributing to long-term visceral hypersensitivity in irritable bowel syndrome.
    Zhang L; Wang R; Chen Y; Yang P; Bai T; Song J; Hou X
    Life Sci; 2022 Apr; 295():120419. PubMed ID: 35183555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal cord plasticity and acid-sensing ion channels involvement in a rodent model of irritable bowel syndrome.
    Matricon J; Gelot A; Etienne M; Lazdunski M; Muller E; Ardid D
    Eur J Pain; 2011 Apr; 15(4):335-43. PubMed ID: 20888277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electroacupuncture Relieves Visceral Hypersensitivity by Down-regulating Mast Cell Number，PAR-2/TRPV 1 Signaling, etc. in Colonic Tissue of Rats with Irritable Bowel Syndrome].
    Deng DX; Tan J; Zhang H; Huang GL; Li S; Guo KK; Wu YY; Yang BY; Xiao Y; Peng L; Xie H
    Zhen Ci Yan Jiu; 2018 Aug; 43(8):485-91. PubMed ID: 30232850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
    Noor-Mohammadi E; Ligon CO; Mackenzie K; Stratton J; Shnider S; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2021 Nov; 379(3):270-279. PubMed ID: 34620725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat.
    Delafoy L; Gelot A; Ardid D; Eschalier A; Bertrand C; Doherty AM; Diop L
    Gut; 2006 Jul; 55(7):940-5. PubMed ID: 16401692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
    Greenwood-Van Meerveld B; Johnson AC; Cochrane S; Schulkin J; Myers DA
    Neurogastroenterol Motil; 2005 Jun; 17(3):415-22. PubMed ID: 15916629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor.
    Long X; Li M; Li LX; Sun YY; Zhang WX; Zhao DY; Li YQ
    Neurogastroenterol Motil; 2018 Apr; 30(4):e13227. PubMed ID: 29052293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
    Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
    J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.
    Marger F; Gelot A; Alloui A; Matricon J; Ferrer JF; Barrère C; Pizzoccaro A; Muller E; Nargeot J; Snutch TP; Eschalier A; Bourinet E; Ardid D
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11268-73. PubMed ID: 21690417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity.
    Ma J; Li J; Qian M; He N; Cao Y; Liu Y; Wu K; He S
    FASEB J; 2019 Dec; 33(12):13560-13571. PubMed ID: 31570003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2X receptor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity.
    Xu GY; Shenoy M; Winston JH; Mittal S; Pasricha PJ
    Gut; 2008 Sep; 57(9):1230-7. PubMed ID: 18270243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome.
    Long Y; Liu Y; Tong J; Qian W; Hou X
    Eur J Pharmacol; 2010 Jun; 636(1-3):159-65. PubMed ID: 20371236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distension technique influences the relationship between colonic and rectal hypersensitivity in irritable bowel syndrome.
    Ng C; Malcolm A; Hansen R; Kellow JE
    Neurogastroenterol Motil; 2006 Mar; 18(3):206-10. PubMed ID: 16487411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
    Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
    Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity.
    Lian B; Vera-Portocarrero L; King T; Ossipov MH; Porreca F
    Brain Res; 2010 Oct; 1358():64-70. PubMed ID: 20727859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.